JP2011510949A5 - - Google Patents

Download PDF

Info

Publication number
JP2011510949A5
JP2011510949A5 JP2010544688A JP2010544688A JP2011510949A5 JP 2011510949 A5 JP2011510949 A5 JP 2011510949A5 JP 2010544688 A JP2010544688 A JP 2010544688A JP 2010544688 A JP2010544688 A JP 2010544688A JP 2011510949 A5 JP2011510949 A5 JP 2011510949A5
Authority
JP
Japan
Prior art keywords
metabolite
ulipristal acetate
patient
uterine
administered
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010544688A
Other languages
English (en)
Japanese (ja)
Other versions
JP5906016B2 (ja
JP2011510949A (ja
Filing date
Publication date
Priority claimed from US12/021,610 external-priority patent/US8299050B2/en
Application filed filed Critical
Publication of JP2011510949A publication Critical patent/JP2011510949A/ja
Publication of JP2011510949A5 publication Critical patent/JP2011510949A5/ja
Application granted granted Critical
Publication of JP5906016B2 publication Critical patent/JP5906016B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010544688A 2008-01-29 2009-01-28 子宮筋腫を治療するための酢酸ウリプリスタルの使用 Expired - Fee Related JP5906016B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12/021,610 2008-01-29
US12/021,610 US8299050B2 (en) 2008-01-29 2008-01-29 Method for treating uterine fibroids
PCT/EP2009/050961 WO2009095418A1 (en) 2008-01-29 2009-01-28 Use of ulipristal for treating uterine fibroids

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015004978A Division JP6138838B2 (ja) 2008-01-29 2015-01-14 子宮筋腫を治療するための酢酸ウリプリスタルの使用

Publications (3)

Publication Number Publication Date
JP2011510949A JP2011510949A (ja) 2011-04-07
JP2011510949A5 true JP2011510949A5 (https=) 2012-03-08
JP5906016B2 JP5906016B2 (ja) 2016-04-20

Family

ID=40551565

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2010544688A Expired - Fee Related JP5906016B2 (ja) 2008-01-29 2009-01-28 子宮筋腫を治療するための酢酸ウリプリスタルの使用
JP2015004978A Expired - Fee Related JP6138838B2 (ja) 2008-01-29 2015-01-14 子宮筋腫を治療するための酢酸ウリプリスタルの使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2015004978A Expired - Fee Related JP6138838B2 (ja) 2008-01-29 2015-01-14 子宮筋腫を治療するための酢酸ウリプリスタルの使用

Country Status (20)

Country Link
US (5) US8299050B2 (https=)
EP (2) EP2252301B1 (https=)
JP (2) JP5906016B2 (https=)
KR (2) KR101571400B1 (https=)
AU (1) AU2009209652B2 (https=)
BR (1) BRPI0907028B8 (https=)
CA (2) CA2713254C (https=)
CY (1) CY1116485T1 (https=)
DK (1) DK2252301T3 (https=)
ES (1) ES2450592T3 (https=)
HR (1) HRP20140132T1 (https=)
IL (2) IL207182A (https=)
MX (1) MX2010008270A (https=)
NZ (1) NZ587439A (https=)
PL (1) PL2252301T3 (https=)
PT (1) PT2252301E (https=)
SI (1) SI2252301T1 (https=)
TW (1) TWI445537B (https=)
WO (1) WO2009095418A1 (https=)
ZA (1) ZA201006049B (https=)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8299050B2 (en) 2008-01-29 2012-10-30 Laboratoire Hra-Pharma Method for treating uterine fibroids
CN107260745A (zh) * 2010-03-22 2017-10-20 利普生物药剂公司 用于抗孕酮的非毒性递送的组合物和方法
EP2471537A1 (en) * 2010-12-30 2012-07-04 PregLem S.A. Treatment of pain associated with dislocation of basal endometrium
EP2545922A1 (en) 2011-07-12 2013-01-16 PregLem S.A. Treatment of excessive menstrual bleeding associated with uterine fibroids
EP2641602A1 (en) * 2012-03-23 2013-09-25 PregLem S.A. Method for treating gynecological diseases
WO2014050105A1 (en) * 2012-09-28 2014-04-03 Aska Pharmaceutical Co., Ltd. Amorphous ulipristal acetate
FR2997628B1 (fr) * 2012-11-08 2015-01-16 Hra Pharma Lab Produit de co-micronisation comprenant un modulateur selectif des recepteurs a la progesterone
FR2997627B1 (fr) * 2012-11-08 2015-01-16 Hra Pharma Lab Produit de co-micronisation comprenant de l'ulipristal acetate
US20150320766A1 (en) * 2012-12-14 2015-11-12 Laboratoire Hra-Pharma Copper intrauterine device
CN103006595B (zh) * 2012-12-25 2018-04-06 江苏亚邦爱普森药业有限公司 制备醋酸优力司特片的方法
US9834575B2 (en) 2013-02-26 2017-12-05 Triact Therapeutics, Inc. Cancer therapy
SG11201507260QA (en) * 2013-04-10 2015-10-29 Preglem Sa Progesteron receptor modulators for use in the therapy of uterine fibroids
US10444958B2 (en) * 2013-09-23 2019-10-15 Adobe Systems Incorporated Visual example-based user interface for adjusting photos along two dimensions
WO2016084070A1 (en) 2014-11-24 2016-06-02 Ramot At Tel-Aviv University Ltd. Pigment epithelium derived factor (pedf) for the treatment of uterine fibroids
WO2017216637A2 (en) 2017-08-04 2017-12-21 Alvogen Malta Operations (Row) Ltd Tablet form including ulipristal acetate and the methods for its preparation
KR102086827B1 (ko) * 2017-12-14 2020-03-10 경희대학교 산학협력단 자궁근육종 치료용 울리프리스탈 아세테이트
KR102043349B1 (ko) * 2018-01-10 2019-11-12 경희대학교 산학협력단 대장암 치료 용도의 울리프리스탈 아세테이트
CN115460926B (zh) 2020-02-19 2023-10-17 菲拉格私人有限责任公司 用于切片和针状骨去除的装置和方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4954490A (en) 1988-06-23 1990-09-04 Research Triangle Institute 11 β-substituted progesterone analogs
US5468741A (en) 1993-05-28 1995-11-21 The Regents Of The University Of California Use of low levels of mifepristone to treat leiomyomata
DE4426601A1 (de) 1994-07-27 1996-02-01 Schering Ag Verwendung eines Kombinationsproduktes enthaltend einen kompetitiven Progesteronantagonisten und ein Gestagen zur Herstellung eines Arzneimittels zur Behandlung der Endometriose oder des Leiomyomata uteri
WO1996023503A1 (de) 1995-02-02 1996-08-08 Schering Aktiengesellschaft Progesteronantagonisten für die herstellung von arzneimitteln zur behandlung von dysfunktionellen uterinen blutungen
US5929262A (en) 1995-03-30 1999-07-27 The United States Of America As Represented By The Department Of Health And Human Services Method for preparing 17α-acetoxy-11β-(4-N, N-dimethylaminophyl)-19-Norpregna-4,9-diene-3, 20-dione, intermediates useful in the method, and methods for the preparation of such intermediates
AU710139B2 (en) 1996-05-01 1999-09-16 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The 21-substituted progesterone derivatives as new antiprogestational agents
TR200001334T2 (tr) 1997-11-14 2000-09-21 Akzo Nobel N.V. Progestojen-anti-progestojen rejimleri.
US6262042B1 (en) 1998-05-29 2001-07-17 Research Triangle Institute 17β-amino and hydroxylamino-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties
FR2827517B1 (fr) 2001-07-23 2003-10-24 Bioalliance Pharma Systemes therapeutiques bioadhesifs a liberation prolongee
ES2212912B1 (es) * 2003-01-22 2005-10-01 Crystal Pharma, S.A. Procedimiento para la obtencion de 17alfa-acetoxi-11beta-(4-n,n-dimetilaminofenil)-19-norpregna-4,9-dien-3,20-diona.
AU2004217988C1 (en) 2003-02-28 2010-06-03 Southwest Foundation For Biomedical Research Method for preparing 17 alpha-acetoxy-11beta-(4-N,N-dimethylaminophenyl)-19-norpregna-4,9-diene-3,20-dione, intermediates thereof, and methods for the preparation of such intermediates
US8865200B2 (en) 2004-07-09 2014-10-21 Laboratoire Hra Pharma Sustained release compositions containing progesterone receptor modulators
US20060251581A1 (en) 2005-05-09 2006-11-09 Mcintyre Jon T Method for treatment of uterine fibroid tumors
AU2006294449A1 (en) 2005-09-29 2007-04-05 Repros Therapeutics Inc. Formulations with improved bioavailability, comprising a steroid derivative and a polyglycolysed glyceride
US8173626B2 (en) * 2006-03-08 2012-05-08 Danco Laboratories Llc Methods, dosing regimens and medications using anti-progestational agents for the treatment of disorders
EA200970646A1 (ru) * 2006-12-28 2009-12-30 Репрос Терапьютикс Инк. Способы и составы для улучшения биодоступности антипрогестинов
PT2148681E (pt) 2007-04-20 2016-06-17 Preglem Sa Moduladores seletivos da progesterona no tratamento da hemorragia uterina
US8299050B2 (en) 2008-01-29 2012-10-30 Laboratoire Hra-Pharma Method for treating uterine fibroids

Similar Documents

Publication Publication Date Title
JP6138838B2 (ja) 子宮筋腫を治療するための酢酸ウリプリスタルの使用
JP2011510949A5 (https=)
KR20140050614A (ko) 자궁 섬유종과 관련된 과다 월경 출혈의 치료
TW201832767A (zh) 治療婦科疾病之組合物
US10172869B2 (en) Progesterone receptor modulators for use in the therapy of uterine fibroids
US20230398127A1 (en) Use of combined oral contraceptives containing nomegestrol acetate and estradiol
Marimuthu et al. Efficacy of different doses of mifepristone in the management of uterine leiomyoma in a tertiary care centre
CN101636166A (zh) 用于预防早产的孕酮
Genazzani et al. 2004 OUTLOOK ON HORMONE REPLACEMENT THERAPY
HK1194297A (en) Treatment of excessive menstrual bleeding associated with uterine fibroids